RankAlpha logo
Back to Rankings

DRUG

Bright Minds BiosciencesF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
DRUG vs peer average
37/100
DRUG vs. peer average (F vs. D)
Grade spread
C 1 · D 6 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

PRAX is the first available peer comparator.

Direct disease-area reference: Praxis develops relutrigine for developmental and epileptic encephalopathies, overlapping BMB-101’s DEE indication. Its programs are further advanced and its portfolio and cash base are much larger, so it is not a direct valuation comparable. [Praxis August 2026 company update](https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-provides-corporate-update-and-20).

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPRAXPraxis Precision Medicines
DRUG
Bright Minds Biosciences
PRAX
Praxis Precision Medicines
Grade
F
F
Momentum
13
11
Value
41
41
Sentiment
41
43
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare top peers (up to 3)

Grade position vs PRAX

DRUG / PRAX
Grade Position
Below peers
DRUG vs. peer average (F vs. D)
37/100
Momentum
13
DRUG
Value
41
DRUG
Sentiment
41
PRAX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DRUG
1
PRAX
PRAX
F
20/100
Even
2
STOK
STOK
D
40/100
+1
3
ENTX
Entera Bio Ltd Common
F
20/100
Even
4
CTMX
CytomX Therapeutics Inc Common
D
40/100
+1
5
AQST
Aquestive Therapeutics Inc Common
D
40/100
+1
PRAX is the first peer returned for this comparison set.